Exelixis | EXEL - EPS Earnings Per Share


Exelixis reported $0.87 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.88 0.78 Nov/03
FY2026Q2 Jun/2026 0.85 0.75 Aug/05
FY2026Q1 Mar/2026 0.87 0.76 0.62 May/05
FY2025Q4 Dec/2025 0.97 0.76 0.55 Feb/10
FY2025Q3 Sep/2025 0.78 0.68 0.47 Nov/04




Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Bayer EUR 2.71 2.09 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Cytokinetics USD -1.67 0.17 Mar/2026
Eisai JPY -11.53 72.47 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Exelixis USD 0.87 0.1 Mar/2026
Genmab DKK 3.69 2.77 Dec/2025
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novartis USD 1.99 0.04 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sanofi EUR 2.17 2.84 Mar/2026
Takeda JPY -15.56 81.3 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Xencor USD -1.71 1.62 Mar/2026